Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
2019 ◽
Vol 28
(5)
◽
pp. 726-733
◽
2018 ◽
Vol 38
(6)
◽
pp. 256-262
◽
Keyword(s):
1983 ◽
Vol 41
◽
pp. 220-221
Keyword(s):
1982 ◽
Vol 40
◽
pp. 724-725
Keyword(s):
1976 ◽
Vol 34
◽
pp. 636-637
1992 ◽
Vol 50
(1)
◽
pp. 186-187
1986 ◽
Vol 44
◽
pp. 548-549
Keyword(s):